Suppression of B-cell proliferation to lipopolysaccharide is mediated through induction of the nitric oxide pathway by tumor necrosis factor-alpha in mice with acute graft-versus-host disease

被引:35
作者
Falzarano, G
Krenger, W
Snyder, KM
Delmonte, J
Karandikar, M
Ferrara, JLM
机构
[1] DANA FARBER CANC INST, DIV PEDIAT ONCOL, BOSTON, MA 02115 USA
[2] CHILDRENS HOSP, BOSTON, MA USA
[3] HARVARD UNIV, SCH MED, DEPT PEDIAT, BOSTON, MA 02115 USA
关键词
D O I
10.1182/blood.V87.7.2853.bloodjournal8772853
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Graft-versus-host disease (GVHD) is associated with impaired B-cell responses. We investigated the mechanism of impaired proliferation of B cells in response to the mitogen lipopolysaccharide (LPS) by analyzing the production of tumor necrosis factor-alpha (TNF-alpha) and nitric oxide (NO), both of which have independently been described as important effector mechanisms in the pathogenesis of acute GVHD. A threefold decrease of mature surface Ig-positive (sIg(+)) B cells was observed in GVHD spleens isolated 2 weeks after transplant. However, proliferation of these cells in response to LPS was suppressed by more than 35-fold. Activated GVHD splenocytes secreted large amounts of TNF-alpha and NO in culture, Neutralization of TNF-alpha with anti-TNF-alpha antibody (Ab) both abrogated NO production and restored LPS-induced proliferation of B cells to levels found in non-GVHD control mice. The specific inhibition of NO synthesis with L(G)-monomethyl-arginine (NNMA) restored splenocyte responses but did not significantly reduce TNF-alpha levels, showing that TNF-alpha per se did not cause immunosuppression. These data show that, during GVHD, induction of the MO pathway is an important mechanism that mediates B-cell hyporesponsiveness to LPS and that this pathway is induced by TNF-alpha. (C) 1996 by The American Society of Hematology.
引用
收藏
页码:2853 / 2860
页数:8
相关论文
共 62 条
[51]   TUMOR-NECROSIS-FACTOR CACHECTIN IS AN EFFECTOR OF SKIN AND GUT LESIONS OF THE ACUTE PHASE OF GRAFT-VS-HOST DISEASE [J].
PIGUET, PF ;
GRAU, GE ;
ALLET, B ;
VASSALLI, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (05) :1280-1289
[52]  
PIGUET PF, 1990, GRAFT VS HOST DISEAS, P255
[53]   ALLOSUPPRESSOR-T-CELL AND ALLOHELPER-T-CELL IN ACUTE AND CHRONIC GRAFT-VS-HOST (GVH) DISEASE .3. DIFFERENT LYT SUBSETS OF DONOR T-CELLS INDUCE DIFFERENT PATHOLOGICAL SYNDROMES [J].
ROLINK, AG ;
GLEICHMANN, E .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (02) :546-558
[54]   MUTUAL RECOGNITION OF PARENTAL AND LYMPHOCYTES-F1 - SELECTIVE ABROGATION OF CYTO-TOXIC POTENTIAL OF LYMPHOCYTES-F1 BY PARENTAL LYMPHOCYTES [J].
SHEARER, GM ;
POLISSON, RP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1980, 151 (01) :20-31
[55]  
SPRINGER TA, 1981, J BIOL CHEM, V256, P3833
[56]   NITRIC-OXIDE - A MACROPHAGE PRODUCT RESPONSIBLE FOR CYTOSTASIS AND RESPIRATORY INHIBITION IN TUMOR TARGET-CELLS [J].
STUEHR, DJ ;
NATHAN, CF .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (05) :1543-1555
[57]   ENUMERATION OF LYMPHOKINE MESSENGER RNA-CONTAINING CELLS INVIVO IN A MURINE GRAFT-VERSUS-HOST REACTION USING THE PCR [J].
TROUTT, AB ;
KELSO, A .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (12) :5276-5280
[58]   CHARACTERIZATION OF A MONOCLONAL ANTIBODY DIRECTED AGAINST MOUSE MACROPHAGE AND LYMPHOCYTE FC-RECEPTORS [J].
UNKELESS, JC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1979, 150 (03) :580-596
[59]  
WALL DA, 1988, J IMMUNOL, V140, P2970
[60]   THE ROLE OF TUMOR-NECROSIS-FACTOR AND INTERFERON-GAMMA IN GRAFT-VERSUS-HOST DISEASE AND RELATED IMMUNODEFICIENCY [J].
WALL, DA ;
SHEEHAN, KCF .
TRANSPLANTATION, 1994, 57 (02) :273-279